Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.99
+0.29 (2.28%)
Aug 22, 2025, 4:00 PM - Market closed
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $340.99 million as of August 25, 2025. Its market cap has increased by 284.18% in one year.
Market Cap
340.99M
Enterprise Value
238.37M
1-Year Change
284.18%
Ranking
Category
Stock Price
$12.99
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $340.99M, a decrease of -84.69%. That is a compound annual growth rate of -15.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 22, 2025 | 340.99M | 16.29% |
Dec 31, 2024 | 293.22M | 3,429.00% |
Dec 29, 2023 | 8.31M | 74.68% |
Dec 30, 2022 | 4.76M | -77.78% |
Dec 31, 2021 | 21.41M | 61.99% |
Dec 31, 2020 | 13.22M | -90.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 638.90B |
Johnson & Johnson | 431.79B |
AbbVie | 372.04B |
UnitedHealth Group | 278.42B |
Novo Nordisk | 253.97B |
AstraZeneca | 251.25B |
Novartis AG | 246.51B |
Abbott Laboratories | 230.77B |